EUVIMEDSkopri EUVIMED
Crossref

Multiple assessments of non‐inferiority trials with ordinal endpoints

Wenfu Xu iD, Yuli Hou, Tong-Yu Lu

Statistics in Medicine · 2023

DOI: 10.1002/sim.9660 ↗

At a glance

Journal article in Statistics in Medicine, 2023. Written by Wenfu Xu and 2 co-authors. Institution: College of Economics and Management, China Jiliang University, Hangzhou, China. Major MEDLINE topics: Models, Statistical, Drug-Related Side Effects and Adverse Reactions. 24 references. Funded by: National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Non‐inferiority (NI) trials are implemented when there is a practical demand to search for alternatives to standard therapies, such as to reduce side effects. An experimental treatment is considered non‐inferior to the standard treatment when it exhibits clinically non‐significant loss of efficacy. Ordinal categorical responses are frequently observed in clinical trials. It has been reported that responses measured using an ordinal scale produce more informative analysis than when responses collapse into binary outcomes. We study the NI trials using ordinal endpoints. We propose a latent variable model for ordinal categorical responses. Based on the proposed latent variable model, the mean efficacy of the different treatments is denoted by the corresponding mean parameter of the underlying continuous distributions. A two‐step procedure is proposed for model identification and parameter estimation. A non‐inferiority analysis can then be conducted based on the latent variable model and the corresponding estimation procedure. We also develop a method and an algorithm to produce an optimal sample size configuration based on the proposed testing procedure. Two clinical examples are provided for demonstrative purposes.

Subjects

MeSH terms (MEDLINE)

Models, StatisticalDrug-Related Side Effects and Adverse ReactionsHumansSample SizeStatistical Distributions

Author keywords

latent variable modelnon-inferiority trialsordinal response

Authors and institutions

  • College of Economics and Management, China Jiliang University, Hangzhou, China.
  • Department of Intelligent Medical, Baidu Company, Beijing, China.

ORCID profiles: Wenfu Xu

Funding

  • National Natural Science Foundation of China

Cite

APA

Xu, W., Hou, Y., & Lu, T. Y. (2023). Multiple assessments of non‐inferiority trials with ordinal endpoints. Statistics in Medicine. https://doi.org/10.1002/sim.9660

Vancouver

Xu W, Hou Y, Lu TY. Multiple assessments of non‐inferiority trials with ordinal endpoints. Statistics in Medicine. 2023. doi:10.1002/sim.9660

BibTeX
@article{Xu2023,
  author = {Xu, Wenfu and Hou, Yuli and Lu, Tong-Yu},
  title = {Multiple assessments of non‐inferiority trials with ordinal endpoints},
  journal = {Statistics in Medicine},
  year = {2023},
  doi = {10.1002/sim.9660}
}
Start for free →